Obesity, inflammation and brachial artery flow-mediated dilatation: Therapeutic targets in patients with microvascular angina (Cardiac Syndrome X)

Cardiovascular Drugs and Therapy

Volumn 26, Issue 3, 2012, Pages 239-244

  Ong, Peter ^a,b   Sivanathan, Ramyya ^a   Borgulya, Gabor ^a   Bizrah, Mukhtar ^a   Iqbal, Yassir ^a   Andoh, Joycelyn ^a   Gaze, David ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Cardiac syndrome X; FMD; Hs CRP; Inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTERY DILATATION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRACHIAL ARTERY FLOW MEDIATED DILATATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; INFLAMMATION; MALE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNDROME X;

ADULT; AGED; BRACHIAL ARTERY; C-REACTIVE PROTEIN; DILATATION; FEMALE; HUMANS; INFLAMMATION; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; OBESITY;

EID: 84864441663     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-012-6382-4     Document Type: Article

References (27)

1. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation. 2004;109:568-72. (Pubitemid 38198862)
2. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499-506.
3. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-40.
4. Lanza GA. Cardiac syndrome X: A critical overview and future perspectives. Heart. 2007;93:159-66. (Pubitemid 46187697)
5. Lekakis JP, Papamichael CM, Vemmos CN, Voutsas AA, Stamatelopoulos SF, Moulopoulos SD. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol. 1998;31:541-6. (Pubitemid 28144118)
6. Masci PG, Laclaustra M, Lara JG, Kaski JC. Brachial artery flowmediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol. 2005;95:1478-80. (Pubitemid 40824774)
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-43. (Pubitemid 34212626)
8. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-9. (Pubitemid 36158034)
9. Sidhu JS, Newey VR, Nassiri DK, Kaski JC. A rapid and reproducible on line automated technique to determine endothelial function. Heart. 2002;88:289-92. (Pubitemid 34913516)
10. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, Creactive protein, and risk of future cardiovascular events. Circulation. 2003;108:2993-9. (Pubitemid 37553568)
11. Lanza GA, Crea F. Primary coronary microvascular dysfunction: Clinical presentation, pathophysiology, andmanagement. Circulation. 2010;121:2317-25.
12. Arroyo-Espliguero R, Mollichelli N, Avanzas P, Zouridakis E, Newey VR, Nassiri DK, Kaski JC. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J. 2003;24:2006-11. (Pubitemid 37420447)
13. López-Jiménez F, Cortés-Bergoderi M. Update: Systemic diseases and the cardiovascular system (i): Obesity and the heart. Rev Esp Cardiol. 2011;64:140-9.
14. Al-Tahami BA, Bee YT, Ismail AA, Rasool AH. Impaired microvascular endothelial function in relatively young obese humans is associated with altered metabolic and inflammatory markers. Clin Hemorheol Microcirc. 2011;47:87-97.
15. De Rosa S, Cirillo P, Pacileo M, Di Palma V, Paglia A, Chiariello M. Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J Vasc Res. 2009;46:609-17.
16. Khera A, Vega GL, Das SR, et al. Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab. 2009;94:3251-8.
17. Gentile M, Panico S, Rubba F, et al. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs- CRP in a cohort of Mediterranean women. Eur J Clin Nutr. 2010;64:873-8.
18. Bagi Z, Feher A, Cassuto J. Microvascular responsiveness in obesity: Implications for therapeutic intervention. Br J Pharmacol. 2012;165:544-60.
19. Teragawa H, Fukuda Y, Matsuda K, et al. Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart. 2004;90:750-4. (Pubitemid 38813633)
20. Atmaca Y, Ozdol C, Turhan S, Vurgun K, Duzen V, Erol C. The association of elevated white blood cell count and C-reactive protein with endothelial dysfunction in cardiac syndrome X. Acta Cardiol. 2008;63:723-8.
21. Sakr SA, Abbas TM, Amer MZ, et al. Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J. 2009;50:407-19.
22. McKendall MJ, Haier RJ. Pain sensitivity and obesity. Psychiatry Res. 1983;8:119-25. (Pubitemid 13194968)
23. Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J. 2003;24:1999-2005. (Pubitemid 37420446)
24. Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Merz CN, Pepine CJ. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). Am Heart J. 2011;162:678-84.
25. Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol. 2001;37:1344-50.
26. Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, Bairey Merz CN. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc. Imaging. 2011;4:514-22.
27. Charakida M, Masi S, Lüscher TF, Kastelein JJ, Deanfield JE. Assessment of atherosclerosis: The role of flow-mediated dilatation. Eur Heart J. 2010;31:2854-61.